|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics. CA cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cidón EU: The challenge of metastatic
colorectal cancer. Clin Med Insights Oncol. 4:55–60. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Janjan NA, Crane C, Feig BW, et al:
Improved overall survival among responders to preoperative
chemoradiation for locally advanced rectal cancer. Am J Clin Oncol.
24:107–112. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang J, Rajput A, Kan JL, et al: Knockdown
of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and
reduces metastasis in human colon carcinoma. J Biol Chem.
284:10912–10922. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park JJ and Lee M: Increasing the α2, 6
sialylation of glycoproteins may contribute to metastatic spread
and therapeutic resistance in colorectal cancer. Gut Liver.
7:629–641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee HJ, Lee M, Kang CM, et al:
Identification of possible candidate biomarkers for local or whole
body radiation exposure in C57BL/6 mice. Int J Radiat Oncol Biol
Phys. 69:1272–1281. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vassos N, Rau T, Merkel S, et al:
Prognostic value of β1 integrin expression in colorectal liver
metastases. Int J Clin Exp Pathol. 7:288–300. 2013.
|
|
8
|
Zhang BH, Pan XP, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
9
|
Zhang BH, Stellwag EJ and Pan XP:
Large-scale genome analysis reveals unique features of microRNAs.
Gene. 443:100–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koturbash I, Zemp FJ, Pogribny I and
Kovalchuk O: Small molecules with big effects: the role of the
microRNAome in cancer and carcinogenesis. Mutat Res. 722:94–105.
2011. View Article : Google Scholar
|
|
11
|
Meng F, Henson R, Lang M, et al:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xia L, Zhang D, Du R, et al: miR-15b and
miR-16 modulate multidrug resistance by targeting BCL2 in human
gastric cancer cells. Int J Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khanna C and Hunter K: Modeling metastasis
in vivo. Carcinogenesis. 26:513–523. 2005. View Article : Google Scholar
|
|
14
|
Duan D, Zheng KX, Shen Y, et al:
Label-free high-throughput microRNA expression profiling from total
RNA. Nucleic Acids Res. 39:e1542011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X and Li W: 5-Fluorouracil in
combination with cisplatin alters the microRNA expression profile
in the CNE nasopharyngeal carcinoma cell line. Mol Med Rep.
6:303–308. 2012.PubMed/NCBI
|
|
16
|
Zhang BH, Stellwag EJ and Pan X:
Large-scale genome analysis reveals unique features of microRNAs.
Gene. 443:100–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yau TO, Wu CW, Dong Y, et al: microRNA-221
and microRNA-18a identification in stool as potential biomarkers
for the non-invasive diagnosis of colorectal carcinoma. Br J
Cancer. 111:1765–1771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saumet A, Mathelier A and Lecellier CH:
The potential of microRNAs in personalized medicine against
cancers. Biomed Res Int. 2014:6429162014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heneghan HM, Miller N and Kerin MJ: MiRNAs
as biomarkers and therapeutic targets in cancer. Curr Opin
Pharmacol. 10:543–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Olson EN: MicroRNAs as therapeutic targets
and biomarkers of cardiovascular disease. Sci Transl Med.
6:239ps32014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang GJ, Kaiser AM, Mills S, et al:
Practice parameters for the management of colon cancer. Dis Colon
Rectum. 55:831–843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Portera CA Jr, Berman RS and Ellis LM:
Molecular determinants of colon cancer metastasis. Surg Oncol.
7:183–195. 1998. View Article : Google Scholar
|
|
23
|
Yokota J: Tumor progression and
metastasis. Carcinogenesis. 21:497–503. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2007. CA Cancer J Clin. 57:43–66. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao W, Shen H, Liu L, et al: MiR-21
overexpression in human primary squamous cell lung carcinoma is
associated with poor patient prognosis. J Cancer Res Clin Oncol.
137:557–566. 2011. View Article : Google Scholar
|
|
26
|
Jiang Y, Zhang M, He H, et al:
MicroRNA/mRNA profiling and regulatory network of intracranial
aneurysm. BMC Med Genomics. 6:362013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sanchez-Diaz PC, Hsiao TH, Chang JC, et
al: De-regulated microRNAs in pediatric cancer stem cells target
pathways involved in cell proliferation, cell cycle and
development. PLoS One. 8:e616222013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zawistowski JS, Nakamura K, Parker JS, et
al: MicroRNA 9–3p targets β1 integrin to sensitize claudin-low
breast cancer cells to MEK inhibition. Mol Cell Biol. 33:2260–2274.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Giles KM, Brown RA, Epis MR, et al:
miRNA-7–5p inhibits melanoma cell migration and invasion. Biochem
Biophys Res Commun. 430:706–710. 2013. View Article : Google Scholar
|
|
30
|
Wang K, Jia Z, Zou J, et al: Analysis of
hsa-miR-30a-5p expression in human gliomas. Pathol Oncol Res.
19:405–411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen G, Shen ZL, Wang L, et al:
Hsa-miR-181a-5p expression and effects on cell proliferation in
gastric cancer. Asian Pac J Cancer Prev. 14:3871–3875. 2013.
View Article : Google Scholar : PubMed/NCBI
|
